SCHEMBL14569540

SCHEMBL14569540

N#Cc1c2ccccc2cc2cc(C=P)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
RELA Q04206 1/20 0.34
MDM4 O15151 1/20 0.34
ERBB2 P04626 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
AHR P35869 1/20 0.33
ANPEP P15144 1/20 0.33
ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14569535 0.82 ALDH1A1 (0.42) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL32211 0.82 ALDH1A1 (0.58) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL29391266 0.82 ALDH1A1 (0.58) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL5211903 0.78 ALDH1A1 (0.50) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL5746993 0.76 MDM4 (0.56) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL12679885 0.76 ALDH1A1 (0.50) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL14558938 0.73 ESR1 (0.36) ALDH1A1KDM4ECA1CA2MDM4
SCHEMBL6324065 0.70 CA1 (0.56) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL1573749 0.70 CA1 (0.50) ALDH1A1KDM4ECA1CA2MEN1
SCHEMBL14558896 0.70 RELA (0.40) ALDH1A1KDM4EMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196225-B2 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2007-03-27 US disclosed